X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

BLOOD

期刊標題檢索 BLOOD 最新評論: Will there be an email for sending out for audit? (2023-04-28)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[BLOOD]您好,您是該頁面的第 111052 位訪客。

期刊簡介
期刊名稱BLOOD BLOOD
LetPub Score
9.8
50 ratings
Rate

Reputation
10.0

Influence
9.7

Speed
9.5

期刊簡稱BLOOD
ISSN0006-4971
E-ISSN1528-0020
h-index426
CiteScore
CiteScoreSJRSNIPCiteScore Rank
23.605.2723.149
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Biochemistry
Q111 / 438
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Hematology
Q16 / 137
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cell Biology
Q118 / 285
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Immunology
Q118 / 236

自引率 (2023-2024)4.30%自引率趨勢
掲載範囲
Blood, the official journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Acceptance of manuscripts is based on the originality and importance of the observations or investigations, the quality of the work and validity of the evidence, the clarity of presentation, and the relevance to our readership and field. All articles are expected to be concise, well organized and clearly written. Authors submit a manuscript with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and is not currently submitted elsewhere for print or electronic publication.

Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Hematopoiesis and Stem Cells; Immunobiology and Immunotherapy scope; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate. Authors are invited to contact the Editor-in-Chief prior to submission if they are uncertain whether their work falls within the general scope of the journal.
官方網站http://bloodjournal.hematologylibrary.org/
在線稿件提交http://submit.bloodjournal.org/
開放訪問No
出版商American Society of Hematology
主題領域医学
出版國/地區UNITED STATES
發行頻率月2回刊行
創刊年1946
每年文章數379每年文章數趨勢
黃金OA百分比26.77%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
HEMATOLOGYSCIEQ12/97
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0006-4971%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 1.0 month(s)
競爭力 *來自作者的數據: Difficult
參考鏈接
相關期刊 【BLOOD】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Journal of Hematology & OncologyH-index: 60

    CiteScore: 48.10
    LEUKEMIAH-index: 176

    CiteScore: 18.10
    AMERICAN JOURNAL OF HEMATOLOGYH-index: 92

    CiteScore: 15.70
    HAEMATOLOGICAH-index: 125

    CiteScore: 14.10
    BLOOD REVIEWSH-index: 85

    CiteScore: 13.80
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGYH-index: 111

    CiteScore: 11.00
    BRITISH JOURNAL OF HAEMATOLOGYH-index: 172

    CiteScore: 8.60
    SEMINARS IN HEMATOLOGYH-index: 88

    CiteScore: 6.20
    HEMATOLOGICAL ONCOLOGYH-index: 42

    CiteScore: 4.20
    CURRENT OPINION IN HEMATOLOGYH-index: 90

    CiteScore: 6.60
    學科內最受檢索的期刊 頁面查看次數
    Journal of Hematology & Oncology101264
    LEUKEMIA58203
    BRITISH JOURNAL OF HAEMATOLOGY50936
    LEUKEMIA & LYMPHOMA44526
    Hematology37484
    ANNALS OF HEMATOLOGY36120
    AMERICAN JOURNAL OF HEMATOLOGY35412
    LEUKEMIA RESEARCH34144
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY32876
    HAEMATOLOGICA27103
  •  

    BLOOD BLOOD
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)
  [BLOOD] 的評論撰寫評論
作者: 黯然佳惠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-28 10:18:39 評論於
Will there be an email for sending out for audit?
(0) 讚! | 黯然佳惠

作者: 碧桃含文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-08 15:19:41 評論於
Carry me, god
(0) 讚! | 碧桃含文

作者: 玉景俊贤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-06 11:18:20 評論於
As for novel cases related to pathology, such as work images in hematology, the cases seen in daily work are very brief. I have seen many published cases. How long will it take to have information about this?
(0) 讚! | 玉景俊贤

作者: 白云邵美


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-05 14:51:49 評論於
Submission rate: 5.0
Sharing experiences: Just received an article. It feels really challenging! I specialize in HBV-HCC for my Master's and Ph.D., and have also published several articles. I only started getting involved in blood diseases two years ago due to work reasons. Submitted on 2022-01-11, had the first chance for revision on 2022-02-03, which took three months. With three reviewers, although their feedback was positive, I had to conduct a lot of experiments on mice. The second revision was on 2022-05-23, and only one reviewer had issues. I requested an additional month from the journal to conduct extensive mouse experiments. Submitted again on 2022-07-22 and finally accepted on 2022-08-04. Many thanks to the associate editor and the three reviewers, as they raised important questions that greatly improved the quality of the article. BLOOD, truly a leading journal in blood diseases. Two words to describe the experience: really difficult
(0) 讚! | 白云邵美

作者: 白云邵美


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-03 18:20:49 評論於
Just received an article. It feels really not easy! I am doing research on HBV-HCC for my master's and PhD, and have also published a few papers. Two years ago, I only started to work on blood diseases due to work reasons. Submitted on 2022-01-11, received the first round of revisions on 2022-02-03, three months later. There were three reviewers, all positive, but many mouse experiments needed to be added. The second round of revisions was completed on 2022-05-23, and only one reviewer still had issues, so I applied for an extra month from the journal and added a large number of mouse experiments. Resubmitted on 2022-07-22. Accepted on 2022-08-04. Many thanks to the associate editor and the three reviewers, they raised important questions that greatly improved the quality of the article. BLOOD, truly the top journal in hematology. Two words to describe the experience: truly difficult
(0) 讚! | 白云邵美

作者: 魔都小柔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-30 10:45:43 評論於
The manuscript number for 2022 has already reached 20,000
(0) 讚! | 魔都小柔

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 11:49:17 評論於
Use Average() to calculate the mean, use STDEV.S() to calculate the standard deviation SD, and use STDEV.S()/COUNT()^0.5 to calculate the standard error SEM
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:36:53 評論於
Plot error bars using ggplot2/excel. In Excel, right-click on the bars, select Format Data Series, click on Error Bars, then select Custom
(0) 讚! | 维尔娜菲茨杰拉德

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 18:08:42 評論於
How to calculate margin of error?
(0) 讚! | Darlene Pepys

作者: 修然小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 14:53:40 評論於
What should I do if error bars are missing on a bar chart?
(0) 讚! | 修然小公主

作者: 天神院梦凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-13 20:12:29 評論於
Give him a refund
(0) 讚! | 天神院梦凝

作者: 云来采蕊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-02 16:03:11 評論於
Submission success rate: 5.0 | Review fee: $75.0Emphasis on research direction: pediatric experience sharing: No response after submitting in the past, was instantly rejected after paying the $75 review fee
(0) 讚! | 云来采蕊

作者: 回风念南


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-06 20:50:49 評論於
Thank you very much for sending your manuscript, referenced above, to Blood. Your paper was carefully reviewed at the editorial level; and while we agree that your work is interesting, we regret to inform you that we will be unable to consider it for publication. The journal does not generally publish single clinical case reports.

Because of high submission rates, Blood can publish only a fraction of the papers received. As a result, a priority system for publication has been established, based not only on quality of the work, but also on relevance to hematology; the definitive and novel nature of the findings reported; and other factors, both intrinsic and relative to other papers submitted to Blood for consideration. We recognize that many good papers are not selected for publication in Blood.

We hope that our expedited editorial decision will allow you to submit your work to another journal with minimal delay.

We greatly appreciate your interest in publishing in Blood.

Sincerely
(0) 讚! | 回风念南

作者: 回风念南


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-06 17:57:49 評論於
No charge
(0) 讚! | 回风念南

作者: 玄冰迎山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-26 11:11:46 評論於
No mail means audit failure
(0) 讚! | 玄冰迎山

作者: Norma Raymond


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-24 16:57:50 評論於
External Auditing
(0) 讚! | Norma Raymond

作者: 蓬莱山甘雨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-27 10:40:49 評論於
Could you please confirm if the status after QC is always "under review"? Will there be any email notification or status change if it is sent for external review (such as changing from "under review" to "peer review")?
(0) 讚! | 蓬莱山甘雨

作者: 猫巷少女筠溪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-24 21:50:23 評論於
Could you please translate the following passage into English and Japanese, using titles ":" and ":"?
(0) 讚! | 猫巷少女筠溪

作者: 玄冰迎山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-04 18:21:21 評論於
I can't remember the feedback on the 18th audit that was submitted
(0) 讚! | 玄冰迎山

作者: 北国紫文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-03 13:30:53 評論於
How long after the internal audit is the external audit conducted?
(0) 讚! | 北国紫文

作者: Gail Gray


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-29 14:36:23 評論於
Research Focus: Leukemia
Experience Sharing: Accepting case studies
(0) 讚! | Gail Gray

作者: 玄冰迎山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-26 21:06:28 評論於
Returned from the external audit in 18 days
(0) 讚! | 玄冰迎山

作者: Edith Wycliffe


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-17 11:14:16 評論於
How long will it take to get the results?
(0) 讚! | Edith Wycliffe

作者: 玄冰迎山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-02 15:45:09 評論於
Submitted for external review and then rejected, some feedback feels a bit one-sided, some can be taken, fight again next time!
(0) 讚! | 玄冰迎山

作者: 韦陀丽萍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-04-17 10:56:07 評論於
Please translate the following paragraph into English and Japanese
(0) 讚! | 韦陀丽萍

首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)

開始撰寫 [BLOOD] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*